The Company's stock has reached the announcement criteria several times recently. The below information is published for investor's information
· Issued by Bora Pharmaceuticals Co Ltd
Close
Today's Information
Provided by: Bora Pharmaceuticals Co., LTD.
SEQ_NO
2
Date of announcement
2022/06/22
Time of announcement
14:50:49
Subject
The Company's stock has reached the announcement
criteria several times recently. The below information
is published for investor's information
Date of events
2022/06/22
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/06/22
2.Cause of occurrence:In accordance the advise from
Taipei Exchange
3.Financial and business information:
Recent Month May 2022 May 2021 YOY Comparison
Revenue(million) 501.80 424.68 18.16%
Income before tax(million) 140.96 33.12 325.59%
Income after tax(million) 93.13 25.33 267.62%
EPS(dollar) 1.37 0.38 263.72%
Recent 2 Month April-May 2022 April-May 2021 YOY Comparison
Revenue(million) 952.36 838.72 13.55%
Income before tax(million) 222.99 99.53 124.05%
Income after tax(million) 156.83 73.71 112.77%
EPS(dollar) 2.30 1.09 110.51%
Recent Quarter 2022 Q1 2021 Q1 YOY Comparison
Revenue(million) 1,117.25 1,367.06 -18.27%
Income before tax(million) 253.02 452.88 -44.13%
Income after tax(million) 179 334.44 -46.42%
EPS(dollar) 2.62 4.96 -47.18%
Recent 4 Quarter 2021 Q2~2022 Q1
Revenue(million) 4,650.08
Income before tax(million) 824.11
Income after tax(million) 594.47
EPS(dollar) 8.69
4.Any material information that needs to be specified
according to Article 4 of Taipei Exchange Procedures
for Verification and Disclosure of Material Information
of Companies with TPEx Listed Securities:
The Company publishes the material inforamtion in
accordance with the guidance from Taipei Exchange,
for more information, please refer to MOPS
5.Any material information in a press conference listed
under Article 11 of Taipei Exchange Procedures for
Verification and Disclosure of Material Information of
Companies with TPEx Listed Securities:NA
6.Any other matters that need to be specified:
Note:April-May 2022 and April-May 2021 numbers are prepared by the
Company in accordance to IFRS. These number are not audit or review
by the CPA, only for investor's reference.
Note:2022 Q1 number has been reviewed by CPA.
Note:Recent 4 quarter's numbers are prepared by the Company in
accordance to IFRS. These number are not audit by the CPA.
註：以上111年4月及5月及去年同期比較數之財務資料係本公司採IFRS會計準則編製
之合併自結數，未經會計師查核(閱)，僅供投資人參考。
註：最近一季111年第1季係指單季數字，係經會計師核閱。
註：最近四季累計係本公司110年第2季至111年第1季採IFRS編製之合併數，係未經會
計師查核。
